Nanotheranostics against COVID-19: From multivalent to immune-targeted materials

Area of Science:

• Nanotechnology
• Virology
• Theranostics

Background:

• The COVID-19 pandemic highlights the urgent need for effective virus mitigation and theranostic agent development.
• Viral heterogeneity and high mutation rates pose significant challenges to developing antiviral drugs, vaccines, and detection methods.
• Classical disinfection methods are insufficient against rapidly mutating viruses like coronaviruses.

Purpose of the Study:

• To explore the potential of nanotechnology-based approaches for addressing challenges posed by viral pandemics, specifically COVID-19.
• To highlight the role of bioengineered nanomaterials in developing advanced theranostic solutions.
• To discuss nanotechnology's application in sensitive virus detection, targeted drug delivery, and immune response modulation.

Main Methods:

• Review of current nanotechnology applications in virology and theranostics.
• Discussion of bioengineered nanomaterials, nanobiosensors, and nanorobots for virus detection and treatment.
• Exploration of multivalent nanomaterials and functionalized nanoparticles for pathogen interaction and immune modulation.

Main Results:

• Bioengineered nanomaterials offer site-specific therapeutic delivery and highly sensitive virus detection.
• Nanotechnology enables real-time monitoring, accelerated diagnostics, and targeted drug delivery to affected organs.
• Functionalized nanoparticles show potential for viral inactivation, immune response modulation, and development of nanovaccines.

Conclusions:

• Nanotechnology presents a promising roadmap for breakthroughs in theranostics for diseases like COVID-19.
• Advanced nanotechnology-based approaches can revolutionize disinfection, diagnostics, and therapeutic strategies against viral pandemics.
• Functionalized nanoparticles hold significant potential for developing effective nanomedicines and nanovaccines to combat viral threats.